ArticleJournal of medical physics
Impact of Grid Size on Dose Calculations for Cranial Tumors.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to evaluate the impact of calculation grid size on dose calculations for multiple cranial tumor types using Monte Carlo (MC) calculation, comparing different grid settings. Methods: This cross-sectional study optimized 110 treatment plans using Elements Cranial and included arteriovenous malformation (AVM), glioblastoma (GBM), meningioma (MGM), brain metastasis (BM), pituitary adenoma (PA), and vestibular schwannoma (VS). Dose coverage at D98%, D95%, and D2%, along with mean dose, were assessed, and other relevant planning and anatomical parameters were analyzed. Results: GBM had the largest gross tumor volume and planning target volume (PTV) volumes, while VS had the smallest volumes and the highest PTV-bone intersection. For MC, grid size variations (1%/1 mm vs. 2%2 mm) did not significantly affect AVM, GBM, or MGM. However, statistically significant dose reductions were observed for BM, PA, and VS. When adjusted for PTV volume and bone intersection, median dose values decreased with the 2%/2 mm grid compared to the 1%/1 mm grid: D98% (25.60 Gy vs. 25.27 Gy, adjusted Conclusions: Grid size impacted dose calculations for small or irregular targets such as BM, PA, and VS. The 2%/2 mm grid led to significant dose reductions and increased CI and GI values.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.